Evidence map›Paper›PMID 33260852›Full record

ArticleSensors (Basel, Switzerland)2020

ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.

Francisco José Vivas Fernández, José Sánchez Segovia, Ismael Martel Bravo, Carlos García Ramos, Daniel Ruiz Castilla, José Gamero López, José Manuel Andújar Márquez

Abstract readValidation Study
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francisco José Vivas FernándezControl and Robotics Research Team (TEP192), University of Huelva, 21004 Huelva, Spain.ORCID 0000-0002-2234-9532
José Sánchez SegoviaStructure of Matter Research Team (FQM318), University of Huelva, 21004 Huelva, Spain.ORCID 0000-0003-0619-964X
Ismael Martel BravoStructure of Matter Research Team (FQM318), University of Huelva, 21004 Huelva, Spain.
Carlos García RamosStructure of Matter Research Team (FQM318), University of Huelva, 21004 Huelva, Spain.
Daniel Ruiz CastillaControl and Robotics Research Team (TEP192), University of Huelva, 21004 Huelva, Spain.
José Gamero LópezControl and Robotics Research Team (TEP192), University of Huelva, 21004 Huelva, Spain.
José Manuel Andújar MárquezControl and Robotics Research Team (TEP192), University of Huelva, 21004 Huelva, Spain.ORCID 0000-0002-0631-0021

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the cure for the SARS-CoV-2 virus (COVID-19) will come in the form of pharmaceutical solutions and/or a vaccine, one of the only ways to face it at present is to guarantee the best quality of health for patients, so that they can overcome the disease on their own. Therefore, and considering that COVID-19 generally causes damage to the respiratory system (in the form of lung infection), it is essential to ensure the best pulmonary ventilation for the patient. However, depending on the severity of the disease and the health condition of the patient, the situation can become critical when the patient has respiratory distress or becomes unable to breathe on his/her own. In that case, the ventilator becomes the lifeline of the patient. This device must keep patients stable until, on their own or with the help of medications, they manage to overcome the lung infection. However, with thousands or hundreds of thousands of infected patients, no country has enough ventilators. If this situation has become critical in the Global North, it has turned disastrous in developing countries, where ventilators are even more scarce. This article shows the race against time of a multidisciplinary research team at the University of Huelva, UHU, southwest of Spain, to develop an inexpensive, multifunctional, and easy-to-manufacture ventilator, which has been named ResUHUrge. The device meets all medical requirements and is developed with open-source hardware and software.

Indexed as

PandemicsSARS-CoV-2Ventilators, MechanicalBiomedical EngineeringCosts and Cost AnalysisCOVID-19Equipment DesignHumansIntermittent Positive-Pressure VentilationPositive-Pressure RespirationSpainUser-Computer InterfaceCOVID-19low-cost ventilatorlung infectionmechanical ventilationnon-invasive ventilation

Identifiers

PMID33260852
PMCPMC7730294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.